Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$2,955,850
-$326,034 QoQ
Shares Held
23,396
-0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#717
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LVW Advisors, LLC holds $27,389,756 across 12 Drug Manufacturers - General names. GILD ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,697 | $6,272,297 | |
| 2 | ABBV |
AbbVie Inc.
|
19,932 | $5,015,688 | |
| 3 | LLY |
ELI LILLY & Co
|
3,596 | $4,313,150 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
23,396 | $2,955,850 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,654 | $2,911,039 | |
| 6 | AMGN |
Amgen Inc
|
7,208 | $2,610,160 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
17,426 | $1,004,086 | |
| 8 | AZN |
Astrazeneca PLC
|
5,241 | $993,798 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,955,850 | 23,396 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $3,281,884 | 23,548 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,678,309 | 21,821 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,214,339 | 19,949 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $2,181,699 | 19,678 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,054,997 | 18,340 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,738,680 | 18,823 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,577,784 | 18,819 | Shares | Sole | 2024-10-09 | |
| 2024-06-30 | $1,158,136 | 16,880 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,873,735 | 25,580 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $1,325,080 | 16,357 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $840,452 | 11,215 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $426,967 | 5,540 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $492,509 | 5,936 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $466,852 | 5,438 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $336,148 | 5,449 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $336,493 | 5,444 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $323,943 | 5,449 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $392,602 | 5,407 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $440,753 | 6,310 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $434,506 | 6,310 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $424,489 | 6,568 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $366,921 | 6,298 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $411,682 | 6,515 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $347,691 | 4,519 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $360,417 | 4,821 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||